Rosemary often steals the headlines when it comes to strengthening hair health and stimulating hair growth. For decades, this aromatic herb has received praise for its ability to thicken hair and ward off thinning. And while rosemary certainly gets its due, there may be another herb that stands a better chance of improving hair health: ginseng. This age-old root is prized for its widespread benefits for health but has become part of the hair care regimen as a result of its strong influences on encouraging hair growth and scalp wellness.
For ages, ginseng is used as an effective adaptogen: this plant enhances general wellness, decreases stress, and boosts mental functioning. Newer research has shown another excellent advantage of ginseng: its promotion of hair growth. Most people have heard of ginseng in the Chinese traditional healing practices, but only over the last decade have researchers started to analyze it on a deeper level and look into its hair-related impacts. As it turns out, this humble root may hold the key to not just healthier hair, but more voluminous, thicker locks.
While genetics undeniably play a significant role in hair loss and thinning, factors such as stress, diet, scalp health, and circulation are all contributing elements that can exacerbate these conditions. This is where ginseng comes into play. It enhances the circulation of blood on its scalp, hence becomes fundamental in hair development and stimulating healthy growth in nourishing the scalp. That more blood flows into it thus enables the strong transport nutrients to the follicle site.
Recent studies have proven that ginseng is a potent herb that promotes hair growth. Red ginseng extract may significantly enhance hair growth, according to a study conducted in the Journal of Medicinal Food. It is crucial for those individuals who experience hair thinning or alopecia because such a discovery opens up a new window of possibilities through natural, herbal interventions.
Active ingredients of ginseng, especially ginsenosides, are considered to play a crucial role in this process. Ginsenosides enhance blood circulation towards the scalp, thereby stimulating hair follicles and increasing keratin production. The latter is a protein responsible for hair strength and structure. Moreover, the mentioned compounds inhibit the action of 5-alpha reductase, which causes male pattern baldness and female pattern hair loss. This helps ginseng in reducing the conversion of testosterone into dihydrotestosterone, a hormone that is responsible for hair loss.
Also Read: This Surprising Chilled Item Can Give You Shiny, Smooth Hair
Aside from promoting hair growth, ginseng also offers a variety of other benefits that can help in creating a healthier scalp and stronger hair. Here are some reasons why ginseng should be part of your hair care routine:
Ginseng is full of antioxidants, which protect your hair from free radicals with harmful oxidative effects. In other words, these little molecules bring about oxidative damage, hair breakage and thinning, and unnatural aging of hair. All these problems are neutralized by powerful antioxidants in Ginseng from the inside hair cells outwards.
Ginseng has natural antimicrobial properties that keep the scalp clean and healthy. This is important in keeping conditions such as dandruff, seborrheic dermatitis, and folliculitis away from the scalp, thus impeding hair growth. A clean and balanced scalp ensures that hair follicles are not obstructed to create an optimal environment for hair to grow.
Another property that is being provided by ginseng is to balance the scalp's natural oils. With fatty acids, it hydrates the scalp without getting greasy, making it ideal for people with both dry and oily scalps. This moisture balance will prevent hair breakage and split ends.
Stress is one of the most significant causes of hair loss, and ginseng is known to have an adaptogenic property. That is, it will make your body capable of resisting the effects of stress much more effectively. Ginseng would indirectly lead to a healthy scalp, as less stress would impact the body. This indirectly minimizes the chances of hair thinning due to the effect of stress factors.
If you want to add ginseng to your hair care process, then there are different ways through which you can do that. Many companies now create hair care products with added ginseng extract: shampoos, conditioners, hair masks- all of it. Thus, you'll be using ginseng without doing much.
Others prefer direct application of the ginseng-infused oils right on the scalp. However, pure ginseng oil can be quite strong, and blending it with a carrier oil like coconut or jojoba oil is suggested for the best results. Just apply this mixture to the scalp and massage it very gently to stimulate blood circulation and nourish the roots of the hair. The oil should be kept for an hour before it should be washed off the oily hair.
Another option is to create a nourishing ginseng hair mask. Combine ginseng powder with olive oil to create a mask that you can apply to your scalp. Leave it on for 20-30 minutes before rinsing thoroughly. This mask not only nourishes the scalp but also helps to repair damaged strands and improve overall hair health.
As with any hair care regimen, consistency is key when using ginseng for hair growth. To see the best results, these ginseng-based products should be used two or three times a week. One must be patient while using ginseng; hair growth is slow and gradual. If one suffers from hair thinning and scalp problems even after consuming ginseng, a visit to a dermatologist or trichologist to determine the underlying conditions will be advisable.
Whereas rosemary has long been the darling of herb enthusiasts claiming to help your hair grow, ginseng has emerged as one of the most powerful tools in the quest for healthy, thick hair. Through its properties of enhancing circulation, feeding the scalp with nutrients, and stimulating growth, ginseng proves to be an excellent remedy for people looking to get healthier-looking hair. Whether you use a commercially available product or make your own DIY treatments, you can enjoy great long-term benefits from ginseng when added to your hair care routine. The good news? It's completely natural and very effective as it supports the overall health of your scalp while fostering thicker, fuller hair.
Active ginseng components in cognitive impairment. Oncotarget. 2018
Antifatigue effects of Panax ginseng. PLoS One. 2013
Credit: iStock
Beyond weight loss and diabetes control, GLP-1 drugs may offer mental health benefits by reducing the need for psychiatric hospital care among people with schizophrenia and type 2 diabetes (T2D), according to a new study published in The Lancet Psychiatry.
The findings showed that treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) was associated with lower risks of psychiatric hospitalization and emergency department visits among people with both conditions.
Also read: Exclusive: GLP-1 Drugs Are The ‘New Statins’, Says University Hospital Birmingham Professor
Researchers from Deakin University and the University of Queensland in Australia analyzed US health records of more than 70,000 adults with schizophrenia and T2D who received treatment between January 2018 and October 2026.
The researchers found that people taking GLP-1 drugs were:
GLP-1 use was also associated with fewer psychiatric emergency department visits. Compared with the same groups, users were:
Further, when the researchers analyzed individual drugs, the association was observed with semaglutide, liraglutide, and tirzepatide, but not dulaglutide.
Read More: Ozempic Baby: Can GLP-1 Drugs Help Women With PMOS Conceive?
The researchers cautioned that the observational study cannot establish that GLP-1 drugs directly reduce the need for acute psychiatric care.
They said the medications should not be considered primary psychiatric treatments or prescribed solely to reduce psychiatric hospitalizations and emergency visits.
Instead, the findings point to a potential additional benefit when GLP-1 drugs are prescribed for appropriate metabolic indications as part of integrated cardiometabolic and mental health care.
“The findings suggest that lower psychiatric acute-care use could be a favourable secondary benefit when GLP-1-based therapies are clinically indicated for metabolic management,” the researchers said.
They added that randomized clinical trials and mechanistic studies are needed to determine whether the drugs have a direct effect on psychiatric outcomes. Further research should also investigate their potential benefits in people with schizophrenia who do not have T2D.
Schizophrenia is a serious psychiatric disorder associated with disability, other health conditions, and premature mortality. Cardiometabolic diseases, including T2D, contribute substantially to this burden.
Studies suggest that diabetes may be up to five times more common among people with schizophrenia than among those without the condition. Approximately one in five people with schizophrenia may also have diabetes.
Several factors may contribute to this increased risk, including:
GLP-1 receptor agonists are an established class of medications used to manage T2D and, in some cases, obesity. Their potential role in people with schizophrenia is of growing interest because of the high burden of metabolic disease in this population.
However, whether these medications directly improve psychiatric outcomes remains uncertain.
The latest findings suggest that GLP-1 treatment may be associated with reduced use of acute psychiatric care among people with schizophrenia and T2D. Further clinical trials are needed before any direct mental health benefit can be established.
Credit: iStock
Originally developed to treat type 2 diabetes and obesity, GLP-1 receptor agonists have shown benefits beyond blood sugar control and weight loss, including for cardiovascular and kidney health.
Some women, particularly those with polyendocrine metabolic ovarian syndrome (PMOS), formerly known
as PCOS, have reported conceiving after taking these medications.
Although GLP-1 drugs can support weight loss and improve metabolic health, evidence that they directly improve fertility remains limited.
For 30-year-old Ashlee Amborn, pregnancy was challenging. According to ABC News, she had PMOS, one functioning fallopian tube and half a uterus, which complicated her chances of conceiving naturally.
After years of fertility treatments, she conceived her first two children. Four months after her second child's birth, she became pregnant again.
Amborn said a GLP-1 drug prescribed to manage her PMOS symptoms, including inflammation and hormonal imbalances, helped her conceive. She became pregnant after taking the medication for a month.
"It was kind of these mixed emotions of, 'Holy cow, I'm pregnant,'" Amborn said. "I did this on my own without fertility treatment. All it took was a GLP-1."
Also read: Sorority Rush Sees Ozempic Trend: What Young Women Should Know Before Using GLP-1 Drugs
A recent review published in the Journal of the Brazilian Reproduction Association (JBRA) Assisted Reproduction suggests a possible association between GLP-1 use and improved fertility outcomes in women with obesity and PMOS, particularly those also taking metformin, a medication used to manage blood sugar.
Weight loss and improved insulin sensitivity may support ovulation and reduce ovarian dysfunction. However, more research is needed to establish whether these medications improve pregnancy or live-birth rates.
Dr. Jacinta Anyaoku, a physician at Maven Clinic specializing in obesity and women's health in midlife, told ABC News that research has not established a direct link between GLP-1 use and ovulation rates, although she has observed potential benefits among her patients.
"When you lose weight, your inflammation goes down," Anyaoku said. "It actually can help with improving your rate of ovulation. Your egg quality could potentially improve if you have reduced inflammation, and so these are all potential effects that come with GLP-1 use."
Sharrón L. Manuel, a board-certified OB/GYN and reproductive endocrinology specialist at HRC Fertility, attributes the reported "Ozempic Baby Boom" largely to weight loss and improved metabolic health, which may help restore ovulation.
Excess body weight can disrupt the hypothalamic-pituitary-ovarian (HPO) axis, contribute to insulin resistance and affect egg and uterine lining quality.
Manuel also points to preliminary research suggesting GLP-1 drugs may influence reproductive function through hormonal regulation, reduced inflammation and improved insulin sensitivity. However, preclinical findings involving ovarian function and endometrial receptivity require further investigation in humans.
Read More: GLP-1 Drugs Ozempic, Zepbound Use Rises 24-Fold Among American Women After Childbirth
GLP-1 drugs should not be used during pregnancy. Women planning to conceive should consult their healthcare professional about stopping treatment. For semaglutide, prescribing guidance recommends discontinuation at least two months before a planned pregnancy.
Women should also seek medical advice about using these medications while breastfeeding.
The American College of Obstetricians and Gynecologists advises against weight-loss medications during pregnancy. Women considering GLP-1 treatment should discuss the risks, benefits and timing with their healthcare professional, particularly if they plan to conceive.
Tirzepatide, sold under the brand names Mounjaro and Zepbound, can affect oral contraceptive absorption. Its prescribing information recommends switching to a non-oral contraceptive method or adding a barrier method for four weeks after starting treatment and for four weeks after each dose increase.
Credit: iStock
Parkinson’s disease (PD) symptoms differ between women and men, a new study has found, with potential implications for treatment.
Presented at the 2026 International Congress of Parkinson’s Disease and Movement Disorders in Seoul, the study found that women experienced more severe motor complications and depression. Men, however, had greater cognitive impairment.
“Sex differences in movement disorders remain understudied and undervalued despite having an important impact on clinical outcomes in both real-life and clinical trial settings,” said Dr. Marina Picillo, assistant professor of neurology at AOU San Giovanni di Dio e Ruggi d’Aragona.
Researchers retrospectively analyzed 10 years of clinical data from more than 10,000 Parkinson’s patients examined at a movement disorders clinic in Germany.
The findings showed that women had a greater burden of motor complications and depression. Men were more likely to experience cognitive impairment, REM sleep behavior disorder (RBD) and loss of smell.
“By analyzing data for more than 10,000 PD patients, this study confirmed that depression is more common in women, while RBD, worse cognition, and poorer olfaction are more prevalent in men,” Picillo said. “With good representation of women (40%), it also confirmed a greater female burden of motor complications.”
The findings highlight the need to account for sex differences in Parkinson’s disease management and clinical trial design, particularly given the historical underrepresentation of women in neurological research. However, the factors underlying these differences remain unclear.
Picillo stressed that considering sex differences when tailoring treatment and designing clinical trials could be an important first step toward precision medicine in Parkinson’s disease.
“This would be the very first, basic step for boosting precision medicine in PD,” she said.
Parkinson’s disease is a progressive neurodegenerative disorder caused by the loss of dopamine-producing nerve cells in the brain.
Common symptoms include tremors, muscle stiffness, slowed movement and impaired balance. As the disease progresses, patients may have difficulty walking, speaking and performing everyday tasks.
The condition can also cause cognitive impairment, depression, anxiety, sleep disturbances, pain and swallowing difficulties, affecting patients’ independence and quality of life. Although it primarily affects older adults, younger people can also develop Parkinson’s disease.
Parkinson’s disease affected an estimated 11.9 million people worldwide in 2021. The number is projected to reach 25.2 million by 2050, a 112% increase.
There is currently no established way to prevent Parkinson’s disease. However, research suggests that certain lifestyle and environmental factors may influence disease risk.
© $2026 Times Horizon Private Limited